Looking for a glow peptide dosing chart PDF? Learn how vial size, reconstitution volume, and syringe units shape GLOW blend research protocols.
There is no official GLOW peptide dosing chart PDF published by the FDA, a medical society, or any regulatory agency. A GLOW blend is a research chemical sold as a lyophilized powder, and every chart circulating online comes from a vendor, a lab, or a user forum. The numbers on those charts depend on the vial size and how much bacteriostatic water you add, not on approved human dosing data.
What the GLOW Peptide Blend Contains
Most suppliers describe GLOW as a three-peptide blend of GHK-Cu, BPC-157, and TB-500. The related "KLOW" version adds KPV, an anti-inflammatory peptide fragment, and is tracked on a separate klow peptide dosing chart.
- GHK-Cu — a copper-binding tripeptide studied for skin and wound repair in laboratory models.
- BPC-157 — a synthetic pentadecapeptide derived from a human gastric protein, studied mainly in animal models.
- TB-500 — a fragment of thymosin beta-4, studied for cell migration and tissue repair in animals.
Ratios vary by supplier. A common 50 mg vial is listed as GHK-Cu 30 mg, BPC-157 10 mg, and TB-500 10 mg. A 70 mg vial is often listed as GHK-Cu 50 mg plus 10 mg of each of the other two. Always check the certificate of analysis instead of assuming the label is accurate.
Why No Official GLOW Peptide Dosing Chart PDF Exists
GLOW peptide is not FDA-approved for human use in the United States, and no clinical trial has tested the blend as a single product. Individual components have been studied, but mostly in rodents and in vitro models rather than in controlled human trials.
The FDA has placed BPC-157 and TB-500 on its Category 2 list of bulk drug substances, which prevents 503A compounding pharmacies from using them. GHK-Cu has also been reviewed by the agency for compounding eligibility. That regulatory picture is exactly why you cannot find a government-issued peptide dosing chart pdf.
Prescription drugs work differently. A wegovy pill dosing chart, for example, is built from phase 3 trial data and manufacturer labeling. Research peptides have no equivalent, so any chart you download is unofficial by definition.
How to Read Any GLOW Peptide Dosing Chart
Every chart starts with two inputs: the total peptide mass in the vial and the volume of bacteriostatic water used to reconstitute it. Those two numbers give you a concentration, and concentration tells you what a mark on an insulin syringe actually delivers.
A standard U-100 insulin syringe measures in "units," where 1 unit equals 0.01 mL. If your solution is 10 mg/mL, then 10 units delivers 1 mg. If it is 20 mg/mL, 10 units delivers 2 mg. Many people misread these charts because they skip that step, which is why a peptide reconstitution chart pdf is often more useful than a dosing chart on its own.
Reconstitution Reference Table
| Total peptide in vial | Bacteriostatic water added | Concentration | 10 units (0.1 mL) delivers | 20 units (0.2 mL) delivers |
|---|---|---|---|---|
| 50 mg | 5 mL | 10 mg/mL | 1.0 mg | 2.0 mg |
| 50 mg | 2.5 mL | 20 mg/mL | 2.0 mg | 4.0 mg |
| 70 mg | 7 mL | 10 mg/mL | 1.0 mg | 2.0 mg |
| 70 mg | 3.5 mL | 20 mg/mL | 2.0 mg | 4.0 mg |
These figures are arithmetic, not medical guidance. They show that a 50 mg vial and a 70 mg vial can deliver the same per-injection amount when the water volume is scaled correctly.
Component-Level Ranges Cited in Research
| Component | Range cited in research and vendor protocols | Frequency cited |
|---|---|---|
| BPC-157 | 200–500 mcg | Once or twice daily |
| TB-500 | 1.5–2.5 mg | Twice weekly |
| GHK-Cu | 1–2 mg | Once daily |
| KPV (KLOW blends only) | 200–500 mcg | Once daily |
These ranges come from animal studies and supplier documentation, not from human trials of the blend. A 50 mg GLOW vial dosed at 1 mg per injection lands near the low end of each component, which is why many beginners start there.
Beginner, Female, and 50 mg vs. 70 mg Considerations
Searches for a glow peptide dose per day for beginners and for a glow peptide dosing chart female usually reflect the same question: how low should the starting point be. Most vendor charts suggest beginning at roughly 1 mg of total blend per day for the first week or two, then adjusting based on tolerance.
Sex is not a dosing variable in any published data on GHK-Cu, BPC-157, or TB-500. Some charts scale doses by body weight instead, but that is a convention borrowed from other compounds rather than an evidence-based rule for this blend.
Vial size changes the math, not the target dose. A 70 mg vial reconstituted to 10 mg/mL behaves the same as a 50 mg vial at 10 mg/mL; the only real difference is how many doses the vial contains.
An aod-9604 peptide dosing chart follows the same reconstitution-first logic, which is a useful sanity check when comparing any two peptide labels.
Safety and Legal Points to Keep in Mind
- GLOW peptide is not FDA-approved for human use, and no dosing chart replaces an evaluation by a licensed clinician.
- Unregulated peptides can be mislabeled, underfilled, or contaminated, so independent third-party testing matters.
- Injection carries risks including infection, injection-site reactions, and allergic response.
- Anyone taking prescription medication should speak with a healthcare professional before adding a research compound.
If you are considering an injectable peptide, bring the product label and certificate of analysis to a physician or pharmacist and ask about interactions and monitoring. An online chart is not a substitute for that conversation, and it should never be treated as a prescription.
Frequently Asked Questions
Is there an official GLOW peptide dosing chart PDF?
No. No government agency or medical organization publishes a GLOW peptide dosing chart because the blend is not an approved drug. Every chart you find online was created by a vendor, a testing lab, or a user forum, and the numbers vary widely between them.
How much GLOW peptide should a beginner start with per day?
Vendor protocols commonly suggest starting near 1 mg of total blend per day for the first week or two, then adjusting. That figure is not supported by human clinical trials of the blend, so it should be discussed with a licensed healthcare professional rather than followed from a chart alone.
Does GLOW peptide dosing differ for women?
Published research on GHK-Cu, BPC-157, and TB-500 does not identify sex-specific dosing. Some online charts scale doses by body weight, but that is a convention borrowed from other compounds, not an evidence-based rule for this blend.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.